FDA Approval Of Hemlibra, Gazyva A Big Positive For Roche

Roche's hemophilia A therapy - Hemlibra - was recently approved by the FDA. This is a big win for Roche, as the drug's estimated peak sales are touted to be as high as $5 billion.